TFF Pharmaceuticals (TFFP) Stock Chart & Stock Price History → RSVP: Charles Payne’s Cash Flow Workshop (From Unstoppable Prosperity) (Ad) Free TFFP Stock Alerts $1.76 -0.11 (-5.88%) (As of 06/7/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TFF Pharmaceuticals Stock Price Performance5 Day Performance-13.73%1 Month Performance-19.27%3 Month Performance-77.69%6 Month Performance-80.57%Year-To-Date Performance-74.93%1 Year Performance-84.91% Receive TFFP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TFF Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsProtect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …Stop right now and do these 3 things to protect yourself TFFP Stock Chart for Sunday, June, 9, 2024 TFFP Chart by TradingView TFF Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/07/2024$1.82$1.76-3.30%$1.89$1.7521,026 shs$5.46 million06/06/2024$1.87$1.82-2.67%$1.91$1.7844,732 shs$5.64 million06/05/2024$2.04$1.87-8.33%$2.12$1.80137,993 shs$5.80 million06/04/2024$2.13$2.04-4.23%$2.16$2.0016,996 shs$6.32 million06/03/2024$2.06$2.13+3.40%$2.13$2.0211,363 shs$6.60 million05/31/2024$2.05$2.06+0.49%$2.11$2.057,100 shs$6.39 million Get the Latest News and Ratings for TFFP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TFF Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/30/2024$2.08$2.05-1.44%$2.20$2.0323,102 shs$6.36 million05/29/2024$2.21$2.08-5.88%$2.28$2.0523,982 shs$6.44 million05/28/2024$2.21$2.21$2.28$2.1631,272 shs$6.85 million05/27/2024$2.21$2.21$2.33$2.0529,900 shs$6.85 million05/24/2024$2.07$2.21+6.76%$2.33$2.0529,991 shs$6.85 million05/23/2024$2.18$2.07-5.05%$2.37$2.04114,721 shs$6.42 million05/22/2024$2.24$2.18-2.68%$2.30$2.1111,174 shs$6.76 million05/21/2024$2.29$2.24-2.18%$2.40$2.0750,800 shs$6.94 million05/20/2024$2.16$2.29+6.02%$2.29$1.9363,341 shs$7.10 million05/17/2024$2.16$2.16$2.23$2.1115,893 shs$6.70 million05/16/2024$2.01$2.16+7.46%$2.48$1.99154,210 shs$5.44 million05/15/2024$1.86$2.01+8.06%$2.14$1.8850,164 shs$5.07 million05/14/2024$1.81$1.86+2.76%$1.99$1.7232,717 shs$4.69 million05/13/2024$1.95$1.81-7.18%$2.04$1.5476,533 shs$4.56 million05/10/2024$2.18$1.95-10.55%$2.33$1.9527,233 shs$4.91 million05/09/2024$2.09$2.18+4.31%$2.21$2.0922,244 shs$5.27 million05/08/2024$2.20$2.09-5.00%$2.20$2.0513,321 shs$5.27 million05/07/2024$2.16$2.20+1.85%$2.47$2.0646,086 shs$5.54 million05/06/2024$2.03$2.16+6.40%$2.30$1.9676,571 shs$5.44 million05/03/2024$2.47$2.03-17.81%$2.67$2.0184,522 shs$5.12 million05/02/2024$2.67$2.47-7.49%$2.83$2.4549,745 shs$6.22 million05/01/2024$2.73$2.67-2.20%$2.80$2.5646,773 shs$6.73 million04/30/2024$2.71$2.73+0.74%$2.84$2.5654,781 shs$6.88 million04/29/2024$2.92$2.71-7.24%$3.18$2.6543,157 shs$6.83 million04/26/2024$3.05$2.92-4.26%$3.17$2.8034,088 shs$7.36 million04/25/2024$3.01$3.05+1.33%$3.10$2.9319,364 shs$7.68 million04/24/2024$3.03$3.01-0.50%$3.13$2.7912,712 shs$7.59 million04/23/2024$2.58$3.03+17.25%$3.14$2.5462,771 shs$7.62 million04/22/2024$3.11$2.58-17.04%$3.06$2.5147,266 shs$6.50 million04/19/2024$3.14$3.11-0.80%$3.41$3.113,671 shs$7.84 million04/18/2024$3.24$3.14-3.26%$3.47$3.0026,469 shs$7.90 million04/17/2024$3.31$3.24-2.10%$3.34$3.2021,779 shs$8.17 million04/16/2024$3.52$3.31-5.97%$3.47$3.2027,068 shs$8.34 million04/15/2024$3.85$3.52-8.57%$4.03$3.5032,246 shs$8.87 millionRSVP: Charles Payne’s Cash Flow Workshop (Ad)Did you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? It's true.Click here to register for free.04/12/2024$3.96$3.85-2.78%$4.26$3.8539,537 shs$9.70 million04/11/2024$4.07$3.96-2.70%$4.37$3.9212,035 shs$9.98 million04/10/2024$4.42$4.07-7.92%$4.59$3.9933,644 shs$10.26 million04/09/2024$4.26$4.42+3.76%$4.52$4.1918,775 shs$11.14 million04/08/2024$4.49$4.26-5.12%$4.61$4.2214,592 shs$10.74 million04/05/2024$4.83$4.49-7.04%$4.91$4.2543,128 shs$11.32 million04/04/2024$5.00$4.83-3.40%$5.27$4.6126,059 shs$12.17 million04/03/2024$4.93$5.00+1.42%$5.15$4.7437,802 shs$12.60 million04/02/2024$6.41$4.93-23.09%$6.34$4.84168,022 shs$11.68 million04/01/2024$6.04$6.41+6.13%$6.81$6.0542,294 shs$15.16 million03/29/2024$6.19$6.04-2.42%$7.17$5.9060,444 shs$14.32 million03/28/2024$6.59$6.19-6.07%$7.17$5.9060,427 shs$14.67 million03/27/2024$6.49$6.59+1.54%$6.85$5.9937,657 shs$15.62 million03/26/2024$7.40$6.49-12.30%$7.45$5.79115,677 shs$15.35 million03/25/2024$7.69$7.40-3.77%$7.99$7.0647,741 shs$17.54 million03/22/2024$8.21$7.69-6.33%$8.20$7.3042,539 shs$18.23 million03/21/2024$7.95$8.21+3.27%$8.25$7.3351,242 shs$19.42 million03/20/2024$8.87$7.95-10.37%$11.00$7.74273,059 shs$18.84 million03/19/2024$7.60$8.87+16.71%$9.74$7.9067,290 shs$21.02 million03/18/2024$7.37$7.60+3.12%$8.02$7.6015,813 shs$18.01 million03/15/2024$7.62$7.37-3.28%$7.90$7.3010,226 shs$17.47 million03/14/2024$7.81$7.62-2.43%$8.10$7.624,887 shs$18.06 million03/13/2024$7.81$7.81$8.91$7.812,053 shs$18.51 million03/12/2024$8.50$7.81-8.12%$9.36$7.8113,601 shs$18.47 million03/11/2024$7.89$8.50+7.73%$8.55$7.657,205 shs$20.15 million03/08/2024$8.24$7.89-4.25%$8.34$7.787,593 shs$18.70 million Related Companies: Aprea Therapeutics Stock Chart TherapeuticsMD Stock Chart Iterum Therapeutics Stock Chart Indaptus Therapeutics Stock Chart Cocrystal Pharma Stock Chart Apollomics Stock Chart Biora Therapeutics Stock Chart Viracta Therapeutics Stock Chart Bullfrog AI Stock Chart BriaCell Therapeutics Stock Chart Receive TFFP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TFF Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TFFP) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredMajor Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TFF Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TFF Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.